Autolus Therapeutics (AUTL) Receivables - Net (2017 - 2026)
Autolus Therapeutics' (AUTL) quarterly Receivables - Net came in at $24.0 million in Q4 2025, up 160060.0% YoY from N/an in Q4 2024, and down 26.32% on a QoQ basis from $32.6 million in Q3 2025.
Autolus Therapeutics (AUTL) Receivables - Net (2017 - 2026) Analysis & Trends
Autolus Therapeutics (AUTL) has 9 years of Receivables - Net data on file, last reported at $24.0 million in Q4 2025.
- Quarterly Receivables - Net rose 160060.0% year-over-year to $24.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.0 million (up 160060.0% YoY) and the FY2025 annual result came in at $24.0 million, up 160060.0% from the prior year.
- Receivables - Net fell to $24.0 million in Q4 2025, from $32.6 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $32.6 million in Q3 2025 to a low of $15000.0 in Q4 2024.
- A 5-year average of $6.0 million and a median of $293000.0 in 2022 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2023 — Receivables - Net slumped 92.1% — and 2025, when it jumped 160060.0%.
- Tracing AUTL's Receivables - Net over 5 years: stood at $384000.0 in 2021, then sank by 68.49% to $121000.0 in 2022, then slipped by 9.92% to $109000.0 in 2023, then sank by 86.24% to $15000.0 in 2024, then jumped by 160060.0% to $24.0 million in 2025.
- The last three Receivables - Net figures came in at $24.0 million (Q4 2025), $32.6 million (Q3 2025), and $26.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.40 Mn |
| Jun 30, 2026 | 44.40 Mn |
| Dec 31, 2025 | 24.02 Mn |
| Dec 31, 2025 | 24.02 Mn |
| Sep 30, 2025 | 32.60 Mn |
| Sep 30, 2025 | 32.60 Mn |
| Jun 30, 2025 | 26.64 Mn |
| Jun 30, 2025 | 26.64 Mn |
| Mar 31, 2025 | 14.32 Mn |
| Mar 31, 2025 | 14.32 Mn |
| Dec 31, 2024 | 15,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Dec 31, 2023 | 109,000.00 |
| Dec 31, 2023 | 109,000.00 |
| Sep 30, 2023 | 165,000.00 |
| Sep 30, 2023 | 165,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 121,000.00 |
| Mar 31, 2023 | 121,000.00 |